Oxygenta Pharmaceutical Limited (BOM:524636)

Oxygenta Pharmaceutical Revenue

Oxygenta Pharmaceutical had revenue of 369.97M INR in the quarter ending June 30, 2026, with 144.45% growth. This brings the company's revenue in the last twelve months to 1.35B, up 20.85% year-over-year. In the fiscal year ending March 31, 2026, Oxygenta Pharmaceutical had annual revenue of 1.13B with 2.39% growth.

• Revenue (ttm): 1.35B
• Revenue Growth: +20.85%
• P/S Ratio: 1.85
• Revenue / Employee: 7.95M
• Employees: 170
• Market Cap: 2.49B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.13B	26.43M	2.39%
Mar 31, 2025	1.11B	708.94M	178.84%
Mar 31, 2024	396.42M	86.55M	27.93%
Mar 31, 2023	309.87M	-295.37M	-48.80%
Mar 31, 2022	605.25M	84.98M	16.33%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error